Calm of Mind
Natural health product licensed in Canada
- Other names
- Women Postpartum
- Licence holder
- Holy Land Traditional Medications Inc.
- NPN or DIN-HM
- 80005853
- Status
- Active licence
- Licence date
- 20 May 2008
- Revision date
- 18 October 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Valeriana officinalis L. (Valerianaceae) | 250 mg | Not calculated |
| Scutellaria lateriflora | 250 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau, Gélatine, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sexe féminin | Not specified | 2 Capsule | maximum: 3 Tous les jours |
| Adultes | Not specified | 3 Capsule | maximum: 1 Tous les jours |
Uses authorised in Canada
Helps to promote sleep/used as a sleep aid. Acts as a sleep aid for people with mild insomnia. Clinically shown to help relieve symptoms associated with menopause. Helps to relieve premenstrual symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking antihypertensives, anti-psychotics and/or blood thinning medication. Consult a health care practitioner prior to use irf you are undergoing theraby for diabetes. Consult a health care practitioner prior to use if you are taking antibiotics. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Exercise caution if operating heavy machinery or driving a motor vehicle within 2 hours of consumption. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Keep out of reach of children
- Effets indésirables connus
None reported.
Source
Official Health Canada record, licence 80005853
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging